Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Scientists discover three new genetic variants linked to male breast cancer
UK scientists have discovered three new genetic changes that increase the risk of breast cancer…
Queensland Brain Cancer Clinical Trial Gives Hope to Patients
Queensland researchers have found that patients who received a cellular immunotherapy for the deadly brain…
Tumour gene test could help to predict ovarian cancer prognosis
A global team of medical researchers led by UNSW have developed a test that could…
Overcoming the evolution of cancer
Cancer evolution can lead to the emergence of drug resistance, so the ICR and The Royal Marsden are working to…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.